Read the First Edition of The Lens, a new magazine by LSI arrow-icon
Learn More About Edison Pharmaceuticals
Edison Pharmaceuticals
Reports Graph
Redox-based drugs targeting rare- or orphan-inherited mitochondrial respiratory chain diseases that are highly debilitating, life-threatening, and have no FDA- or EMA-approved drugs available to treat them
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next